Individual Padua VTE risk factors identified by admitting prescribers and the SME
| . | Admitting provider, n (%) . | SME, n (%) . | Agreement (%) . | κ . |
|---|---|---|---|---|
| Age ≥70 years (1 point) | 945 (23.5) | 968 (24.1) | 99.4 | 0.9842 |
| Ongoing hormone treatment (1 point) | 2 (<0.1) | 38 (0.9) | 99.0 | 0.0491 |
| Recent surgery or trauma (2 points) | 29 (0.7) | 53 (1.3) | 98.2 | 0.0891 |
| Known thrombophilia (3 points) | 103 (2.6) | 26 (0.6) | 97.5 | 0.2246 |
| Acute MI or ischemic stroke (1 point) | 5 (0.1) | 178 (4.4) | 95.4 | −0.0024 |
| Active cancer (3 points) | 78 (1.9) | 277 (6.9) | 94.2 | 0.3174 |
| History of VTE (3 points) | 615 (15.3) | 596 (14.8) | 92.5 | 0.7054 |
| Obesity (1 point) | 1137 (28.3) | 1368 (34.0) | 88.9 | 0.7430 |
| Respiratory or heart failure (1 point) | 1069 (26.6) | 824 (20.5) | 78.5 | 0.4054 |
| Reduced mobility (3 points) | 187 (4.7) | 1284 (31.9) | 67.8 | 0.0419 |
| Acute infection or rheumatologic disorder (1 point) | 255 (6.3) | 1681 (41.8) | 63.1 | 0.1398 |
| . | Admitting provider, n (%) . | SME, n (%) . | Agreement (%) . | κ . |
|---|---|---|---|---|
| Age ≥70 years (1 point) | 945 (23.5) | 968 (24.1) | 99.4 | 0.9842 |
| Ongoing hormone treatment (1 point) | 2 (<0.1) | 38 (0.9) | 99.0 | 0.0491 |
| Recent surgery or trauma (2 points) | 29 (0.7) | 53 (1.3) | 98.2 | 0.0891 |
| Known thrombophilia (3 points) | 103 (2.6) | 26 (0.6) | 97.5 | 0.2246 |
| Acute MI or ischemic stroke (1 point) | 5 (0.1) | 178 (4.4) | 95.4 | −0.0024 |
| Active cancer (3 points) | 78 (1.9) | 277 (6.9) | 94.2 | 0.3174 |
| History of VTE (3 points) | 615 (15.3) | 596 (14.8) | 92.5 | 0.7054 |
| Obesity (1 point) | 1137 (28.3) | 1368 (34.0) | 88.9 | 0.7430 |
| Respiratory or heart failure (1 point) | 1069 (26.6) | 824 (20.5) | 78.5 | 0.4054 |
| Reduced mobility (3 points) | 187 (4.7) | 1284 (31.9) | 67.8 | 0.0419 |
| Acute infection or rheumatologic disorder (1 point) | 255 (6.3) | 1681 (41.8) | 63.1 | 0.1398 |
MI, myocardial infarction.